Latest news with #JamieMains
Straits Times
17-07-2025
- Health
- Straits Times
Upended by meth, some US communities are paying users to quit
Six months after a doctor told her no medication existed for addiction to meth, Ms Jamie Mains heard about a program that would reward her for abstaining. Ms Jamie Mains showed up for her checkup so high that there was no point in pretending otherwise. At least she wasn't shooting fentanyl again; medication was suppressing those cravings. Now it was methamphetamine that manacled her, keeping her from eating, sleeping, thinking straight. Still, she could not stop injecting. 'Give me something that's going to help me with this,' she begged her doctor. 'There is nothing,' the doctor replied. Overcoming meth addiction has become one of the biggest challenges of the national drug crisis. Fentanyl deaths have been dropping, in part because of medications that can reverse overdoses and curb the urge to use opioids. But no such prescriptions exist for meth, which works differently on the brain. In recent years, meth, a highly addictive stimulant, has been spreading aggressively across the country, rattling communities and increasingly involved in overdoses. Lacking a medical treatment, a growing number of clinics are trying a startlingly different strategy: To induce patients to stop using meth, they pay them. The approach has been around for decades, but most clinics were uneasy about adopting it because of its bluntly transactional nature. Patients typically come in twice a week for a urine drug screen. If they test negative, they are immediately handed a small reward: a modest store voucher, a prize or debit card cash. The longer they abstain from use, the greater the rewards, with a typical cumulative value of nearly US$600 (S$770). The programmes, which usually last three to six months, operate on the principle of positive reinforcement, with incentives intended to encourage repetition of desired behavior – somewhat like a parent who permits a child to stay up late as a reward for good grades. Top stories Swipe. Select. Stay informed. Business Market versus mission: What will Income Insurance choose? Singapore Over 600 Telegram groups in Singapore selling, advertising vapes removed by HSA Singapore 2 weeks' jail for man caught smuggling over 1,800 vapes and pods into Singapore Life First look at the new Singapore Oceanarium at Resorts World Sentosa Opinion AI and education: We need to know where this sudden marriage is heading Singapore Coffee Meets Bagel's Singpass check: Why I'll swipe right on that Singapore Jail for man who fatally hit his daughter, 2, while driving van without licence Sport 'Like being in a washing machine with 40 deg C water': Open water swimmers brave challenging conditions Research shows that the approach, known in addiction treatment as 'contingency management', or CM, produces better outcomes for stimulant addiction than counselling or cognitive behavioural therapy. Follow-up studies of patients a year after they successfully completed programs show that about half remained stimulant-free. Even those who are uncomfortable with the general concept are starting to come around, said Dr Sally Satel, medical director at a methadone clinic in Washington, and a senior fellow at the American Enterprise Institute. 'Most people recoil at paying people to do the right thing,' she said. 'But we've got plenty of data that shows this works. So I think we just have to bite the utilitarian bullet.' Until recently, the Department of Veterans Affairs health system was one of the few to adopt CM; the agency has treated over 8,000 veterans with it since 2011. During the pandemic, as meth-related fatalities climbed, the Biden administration gingerly increased federal support, allowing states to apply for Medicaid money to fund rewards. In its final days, the administration boosted substantially the amount that clinics receiving federal grants could award to patients. Now, CM is in a period of fast-moving growth. Some private employers are authorizing company health insurance to cover it. New apps allow patients in far-flung rural areas to use telehealth CM. Programs are trying out increased amounts and an assortment of gift cards to learn which reward structures individual patients respond to best. A programme in Pennsylvania's Allegheny County rewards patients up to US$1,000 a year. Treatment experts estimate there now are more than 600 CM sites nationwide, including 109 in California, which is building a statewide project. In January, San Francisco began a programme called 'Cash Not Drugs'. But addiction experts worry that under the Trump administration, CM programs will be difficult to sustain, much less expand to meet the need. Many believe that Robert F. Kennedy Jr, the health secretary, who overcame his heroin addiction with a 12-step programme and has praised approaches that threaten to jail people who refuse treatment, would be unlikely to endorse a financial rewards-based strategy. Ms Jamie Mains holds out her one-year sobriety token (left) from Narcotics Anonymous that she keeps on her key chain. PHOTO: GRETA RYBUS/NYTIMES The Department of Health and Human Services did not respond to questions about CM or meth use, instead issuing a statement saying the agency would not address 'potential policy decisions.' 'HHS must return to commonsense public health approaches focused on prevention, treatment and long-term recovery,' the statement said. With research indicating that programs with greater rewards and longer duration produce better results, the long-standing criticism of CM could resurface and be amplified: that tax dollars are being used to bribe people not to do drugs. Why there's no medication for meth The search for a medication to curb stimulant addiction continues. It's a formidable mission. For people addicted to opioids, treatment usually consists of medications that contain low-grade opioids, which satisfy cravings without inducing a high. That effect is far more difficult to achieve in people addicted to meth. As Dr Kristen B. Silvia, who oversees a hospital-based CM program in Portland, Maine, through MaineHealth, explains to patients: Meth causes the brain to release exorbitant amounts of dopamine, the feel-good neurotransmitter. On a ho-hum day, she tells them, an individual's dopamine levels could rise to, say, 50. 'If you have the best meal ever, the best sex ever, the best day of your life, you can get your levels up to 100.' When someone uses crack, another stimulant, within seconds their levels rise to 300, she continues, 'or three times the best day of your life'. But on meth, dopamine levels skyrocket to 1,000 and can remain there for hours: 'No medication can safely compete with that.' Ms Jamie Mains attends a bible study meeting to support her recovery, in Lewiston, Maine, on June 27. PHOTO: GRETA RYBUS/NYTIMES Given the ferocity of meth addiction, it almost defies credulity that small rewards can quell drug hunger. But treatment experts say that as negative screening results accrue and abstinence builds, the immediacy of a reward and the ability to purchase something satisfying can bathe the brain in cascades of frequent, modest dopamine jolts. Appetite returns. So does sleep. And patients become more amenable to counseling. That is what Ms Mains experienced. Six months after her doctor told her no medication existed for meth, she heard, in early 2024, about a pilot CM programme at Spurwink, a clinic in Portland. Ms Mains, 43, was desperate to get sober to be allowed to visit her young grandson. She hadn't believed that would ever happen. 'But for me,' she said, 'money was a good enough reason to try.' She moved into a shelter to white-knuckle through withdrawal. Her first negative urine screening earned her US$10 on a debit card plus encouraging nods and warm smiles from the clinic staff. The second negative test that week got her US$12.50 more. She used the money to buy months-late Christmas gifts for her grandson. She could not remember when exhilaration had sprung from pride and joy, rather than from drugs. With each negative drug screen, Ms Mains' rewards inched up, peaking at about US$65. Her life began to improve. She moved to a sober house, started volunteering at a thrift shop and began going to church three times a week. She regularly attended recovery meetings, learning to face the painful trauma that drugs had long cloaked: at 9, she had started binge-drinking; at 12, her mother had given her a taste of heroin. Ms Jamie Mains, 43, was desperate to get sober to be allowed to visit her young grandson. PHOTO: GRETA RYBUS/NYTIMES The funding of CM programmes remains an issue. In 2021, Medicaid, which did not cover contingency management, permitted states to apply for pilot programs, an arduous process. Only a handful, including California, Montana and Washington, have so far passed muster. As meth use grew and the success of CM became better known, some 40 states lobbied federal authorities to allow greater awards for enrolled patients. In January, the Biden administration raised the cumulative cap on federal grants for CM awards to US$750 per patient from US$75, provided that awards are issued as gift cards or services, not cash. Uncertain about whether these policies will continue under the Trump administration, some public health officials have been seeking grants from local and state opioid litigation settlement funds. According to the National Academy of State Health Policy, more places, including Michigan, Rhode Island, Vermont, Virginia and Arizona's Maricopa County, have started CM programs with settlement money. Today, 16 months after Ms Mains took her first negative urine test in the CM program, she has stopped using alcohol and illegal drugs. Temptation is omnipresent. But even during a car ride to the funeral of a beloved aunt, as her stepmother smoked crack in the back seat, she said, she managed to resist. 'I was getting paid not to use and that was nice and that was the beginning,' she said. 'But now I feel like being sober is payment enough, not waking up sick is payment enough, being trusted is payment enough.' NYTIMES
New York Times
16-07-2025
- Health
- New York Times
Upended by Meth, Some Communities Are Paying Users to Quit
Jamie Mains showed up for her checkup so high that there was no point in pretending otherwise. At least she wasn't shooting fentanyl again; medication was suppressing those cravings. Now it was methamphetamine that manacled her, keeping her from eating, sleeping, thinking straight. Still, she could not stop injecting. 'Give me something that's going to help me with this,' she begged her doctor. 'There is nothing,' the doctor replied. Overcoming meth addiction has become one of the biggest challenges of the national drug crisis. Fentanyl deaths have been dropping, in part because of medications that can reverse overdoses and curb the urge to use opioids. But no such prescriptions exist for meth, which works differently on the brain. In recent years, meth, a highly addictive stimulant, has been spreading aggressively across the country, rattling communities and increasingly involved in overdoses. Lacking a medical treatment, a growing number of clinics are trying a startlingly different strategy: To induce patients to stop using meth, they pay them. The approach has been around for decades, but most clinics were uneasy about adopting it because of its bluntly transactional nature. Patients typically come in twice a week for a urine drug screen. If they test negative, they are immediately handed a small reward: a modest store voucher, a prize or debit card cash. The longer they abstain from use, the greater the rewards, with a typical cumulative value of nearly $600. The programs, which usually last three to six months, operate on the principle of positive reinforcement, with incentives intended to encourage repetition of desired behavior — somewhat like a parent who permits a child to stay up late as a reward for good grades. Research shows that the approach, known in addiction treatment as 'contingency management,' or CM, produces better outcomes for stimulant addiction than counseling or cognitive behavioral therapy. Follow-up studies of patients a year after they successfully completed programs show that about half remained stimulant-free. Want all of The Times? Subscribe.
